Andrew Guggenhime - 02 Sep 2025 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
PRESIDENT AND CFO
Signature
Andrew Guggenhime, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol
PCVX
Transactions as of
02 Sep 2025
Net transactions value
-$160,325
Form type
4
Filing time
04 Sep 2025, 16:10:42 UTC
Previous filing
09 Apr 2025
Next filing
10 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GUGGENHIME ANDREW PRESIDENT AND CFO C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS Andrew Guggenhime, by /s/ Peter N. Efremenko, Attorney-In-Fact 04 Sep 2025 0001230724

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Tax liability $40,081 -1,270 -0.96% $31.56 131,009 02 Sep 2025 Direct F1, F2
transaction PCVX Common Stock Tax liability $75,144 -2,381 -1.8% $31.56 128,628 02 Sep 2025 Direct F1
transaction PCVX Common Stock Tax liability $45,099 -1,429 -1.1% $31.56 127,199 02 Sep 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
F2 Includes 329 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2025.